MedPath

Marzole

Brand Name: Marzole

Generic Name: Omeprazole (as Sodium)

Active
Registration Number

DRP-6422-04

Dosage Form

Lyophilized Powder For Injection (I.V.)

Issuance Date

April 1, 2025

Expiry Date

April 1, 2031

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg
PackagingUSP Type I Clear and Colorless Glass Vial (for the lyophilized powder) + 10mL USP Type I clear and colorless glass ampoule [Diluent (0.9% Sodium Chloride)] in Aluminum PVC Blister Pack (box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Proton Pump Inhibitor
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Omeprazole (as Sodium)Active
Monograph: omeprazole (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform